MedTrace Logo

COVID-19 Citizen Science Expansion Project

NCT05548803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54689

Last updated 2024-11-01

No results posted yet for this study

Summary

COVID-19 Citizen Science (CCS), launched in March 2020, supports collaborative research on symptoms, risk factors, surveillance, biomarkers and testing for COVID-19 using the Eureka Research Platform. CCS maintains IRB approval with UCSF's IRB (UCSF IRB# 17-21879).

This CCS Expansion Project, which is funded jointly by the National Institutes of Health (NIH), the Patient-Centered Outcomes Research Institute (PCORI), and the Bill and Melinda Gates Foundation, will invite patients at health systems across the US to contribute their health records data and then join the established CCS study, allows for linked analysis of CCS data and health records data, and provides the scientific rationale and plan for the project.

Conditions

  • Covid19

Sponsors & Collaborators

  • Sutter Health

    collaborator OTHER

  • Carelon Research

    collaborator OTHER

  • Louisiana Public Health Institute

    collaborator OTHER

  • Duke University

    collaborator OTHER

  • New York University

    collaborator OTHER

  • Albert Einstein College of Medicine

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • Ochsner Health System

    collaborator OTHER

  • Baylor Scott and White Health

    collaborator OTHER

  • Wake Forest University Health Sciences

    collaborator OTHER

  • New York City Health and Hospitals Corporation

    collaborator OTHER

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Mark Pletcher, MD, MPH · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-24
Primary Completion
2024-09-01
Completion
2024-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05548803 on ClinicalTrials.gov